These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
244 related articles for article (PubMed ID: 25095748)
1. Clinicopathological and prognostic significance of p53, Ki-67, and Bcl-2 expression in Tunisian gastric adenocarcinomas. Ayed DB; Khabir A; Abid M; Bayrouti MI; Gargouri A; Sellami-Boudawara T; Mokdad-Gargouri R Acta Histochem; 2014 Oct; 116(8):1244-50. PubMed ID: 25095748 [TBL] [Abstract][Full Text] [Related]
2. The prognostic significance of p53 and bcl-2 expression in lung adenocarcinoma and its correlation with Ki-67 growth fraction. Ishida H; Irie K; Itoh T; Furukawa T; Tokunaga O Cancer; 1997 Sep; 80(6):1034-45. PubMed ID: 9305703 [TBL] [Abstract][Full Text] [Related]
3. Expression of Bcl-2 and p53 correlates with the morphology of gastric neoplasia. Kyokane K; Ito M; Sato Y; Ina K; Ando T; Kusugami K J Pathol; 1998 Apr; 184(4):382-9. PubMed ID: 9664903 [TBL] [Abstract][Full Text] [Related]
4. The potential role of Bcl-2 expression, apoptosis and cell proliferation (Ki-67 expression) in cases of gastric carcinoma and correlation with classic prognostic factors and patient outcome. Tsamandas AC; Kardamakis D; Tsiamalos P; Liava A; Tzelepi V; Vassiliou V; Petsas T; Vagenas K; Zolota V; Scopa CD Anticancer Res; 2009 Feb; 29(2):703-9. PubMed ID: 19331225 [TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical expression of bcl-2 in Dukes' stage B and C colorectal carcinoma patients: correlation with p53 and ki-67 in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2005; 56(4):179-85. PubMed ID: 16477877 [TBL] [Abstract][Full Text] [Related]
7. Bcl-2 expression as a prognostic factor of survival of gastric carcinoma. Inada T; Kikuyama S; Ichikawa A; Igarashi S; Ogata Y Anticancer Res; 1998; 18(3B):2003-10. PubMed ID: 9677457 [TBL] [Abstract][Full Text] [Related]
8. The prevalence of bcl-2, p53, and Ki-67 immunoreactivity in transitional cell bladder carcinomas and their clinicopathologic correlates. Nakopoulou L; Vourlakou C; Zervas A; Tzonou A; Gakiopoulou H; Dimopoulos MA Hum Pathol; 1998 Feb; 29(2):146-54. PubMed ID: 9490274 [TBL] [Abstract][Full Text] [Related]
9. KLF4 expression and apoptosis-related markers in gastric cancer. Krstic M; Stojnev S; Jovanovic L; Marjanovic G J BUON; 2013; 18(3):695-702. PubMed ID: 24065485 [TBL] [Abstract][Full Text] [Related]
10. The correlation between the immunostains for p53 and Ki67 with bcl-2 expression and classical prognostic factors in colorectal carcinomas. Gurzu S; Jung J; Mezei T; Pávai Z Rom J Morphol Embryol; 2007; 48(2):95-9. PubMed ID: 17641794 [TBL] [Abstract][Full Text] [Related]
11. Apoptosis and immunohistochemical bcl-2 expression in colorectal adenomas and carcinomas. Aspects of carcinogenesis and prognostic significance. Baretton GB; Diebold J; Christoforis G; Vogt M; Müller C; Dopfer K; Schneiderbanger K; Schmidt M; Löhrs U Cancer; 1996 Jan; 77(2):255-64. PubMed ID: 8625232 [TBL] [Abstract][Full Text] [Related]
12. Extent, relationship and prognostic significance of apoptosis and cell proliferation in synovial sarcoma. Sun B; Sun Y; Wang J; Zhao X; Wang X; Hao X Eur J Cancer Prev; 2006 Jun; 15(3):258-65. PubMed ID: 16679870 [TBL] [Abstract][Full Text] [Related]
13. Clinical contribution of bcl-2, p53 and Ki-67 proteins in pancreatic ductal adenocarcinoma. Mäkinen K; Hakala T; Lipponen P; Alhava E; Eskelinen M Anticancer Res; 1998; 18(1B):615-8. PubMed ID: 9568186 [TBL] [Abstract][Full Text] [Related]
15. Prognostic use of growth characteristics of early gastric cancer and expression patterns of apoptotic, cell proliferation, and cell adhesion proteins. Pan W; Ishii H; Ebihara Y; Gobe G J Surg Oncol; 2003 Feb; 82(2):104-10. PubMed ID: 12561066 [TBL] [Abstract][Full Text] [Related]
16. Correlation of p53 and Ki-67 (MIB-1) expressions with clinicopathological features and prognosis of early stage cervical squamous cell carcinomas. Hanprasertpong J; Tungsinmunkong K; Chichareon S; Wootipoom V; Geater A; Buhachat R; Boonyapipat S J Obstet Gynaecol Res; 2010 Jun; 36(3):572-80. PubMed ID: 20598040 [TBL] [Abstract][Full Text] [Related]
17. Prognostic significance of biological apoptosis factors in gastric cancer. Sezer C; Yildirim M; Yildiz M; Sezgin A; Donem Dilli U; Goktas S; Bulbuller N J BUON; 2013; 18(1):138-46. PubMed ID: 23613399 [TBL] [Abstract][Full Text] [Related]
18. Prediction of aggressiveness of gastrointestinal stromal tumours based on immunostaining with bcl-2, Ki-67 and p53. Meara RS; Cangiarella J; Simsir A; Horton D; Eltoum I; Chhieng DC Cytopathology; 2007 Oct; 18(5):283-9. PubMed ID: 17883690 [TBL] [Abstract][Full Text] [Related]
19. Bcl-2 protein expression is associated with p27 and p53 protein expressions and MIB-1 counts in breast cancer. Tsutsui S; Yasuda K; Suzuki K; Takeuchi H; Nishizaki T; Higashi H; Era S BMC Cancer; 2006 Jul; 6():187. PubMed ID: 16839413 [TBL] [Abstract][Full Text] [Related]
20. Immunohistochemical expression of bcl-2 in UICC stage I and III colorectal carcinoma patients: correlation with c-erbB-2, p53, ki-67, CD44, laminin and collagen IV in evaluating prognostic significance. Zavrides H; Zizi-Sermpetzoglou A; Elemenoglou I; Papatheofanis I; Peros G; Athanasas G; Panousopoulos D Pol J Pathol; 2006; 57(3):149-59. PubMed ID: 17219742 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]